Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 450, Issue 1-2, 2000, Pages 167-180

  Van Steeg, Harry ^a   Mullenders, Leon H F ^b   Vijg, Jan ^c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CTRC Institute for Drug Development   (United States)

Author keywords

DNA repair gene; Hprt gene; lacZ reporter gene; Mutagenicity; p53 gene; ras gene; UV light; Xeroderma pigmentosum

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; N (2 FLUORENYL)ACETAMIDE; NUCLEOTIDE; PROTEIN P53;

ANIMAL MODEL; CANCER RISK; CHEMICAL CARCINOGENESIS; EXCISION REPAIR; GENE MUTATION; GENETIC DISORDER; KNOCKOUT MOUSE; MOUSE; MUTAGENESIS; MUTATION; MUTATION RATE; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; ULTRAVIOLET B RADIATION; XERODERMA PIGMENTOSUM;

EID: 0034732996     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(00)00023-3     Document Type: Article

References (60)

1. Bishop J.M. Molecular themes in oncogenesis. Cell. 64:1991;235-248.
2. Fearon E.R., Vogelstein B A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
3. Gupta R.C., Lutz W.K. Background DNA damage for endogenous and unavoidable exogenous carcinogens: a basis for spontaneous cancer incidence? Mutat. Res. 424:1999;1-8.
4. Sugimura T., Nagao M., Wakabayashi K. Carcinogenicity of food mutagens. Environ. Health Perspect. 104:1996;429-433.
5. Minamoto T., Mai M., Ronai Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis. 20:1999;519-527.
6. Cardiff R.D., Sinn E., Muller W., Leder P. Transgenic oncogene mice. Tumor phenotype predicts genotype. Am. J. Pathol. 139:1991;495-501.
7. Morgenbesser S.D., DePinho R.A. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin. Cancer Biol. 5:1994;21-36.
8. Merlino G. Transgenic mice as models for tumorigenesis. Cancer Invest. 12:1994;203-213.
9. Breuer M., Slebos R., Verbeek S., van Lohuizen M., Wientjens E., Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature. 340:1989;61-63.
10. Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene. 5:1990;1195-1200.
11. Tennant R.W., Spalding J., French J.E. Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat. Res. 365:1996;119-127.
12. Friedberg E.C., Walker G.C., Siede W. DNA repair and mutagenesis. 1995;ASM Press, Washington, DC.
13. Bootsma D., Kraemer K.H., Cleaver J.E., Hoeijmakers J.H.J. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Vogelstein B., Kinzler K.W. The Genetic Basis of Human Cancer. 1998;245-274. Chapter 13.
14. Jiricny J. Colon cancer and DNA repair: have mismatches met their match? Trends Genet. 10:1994;164-168.
15. Ford J.M., Hanawalt P.C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci., U.S.A. 92:1995;8876-8880.
16. van Steeg H., Kraemer K.H. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol. Med. Today. 5:1999;86-94.
17. Jones I.M., Burkhart-Schultz K., Carrano A.V. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. Mutat. Res. 147:1985;97-105.
18. Tates A.D., van Dam F.J., de Zwart F.A., van Teylingen C.M., Natarajan A.T. Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene. Mutat. Res. 309:1994;299-306.
19. Winton D.J., Blount M.A., Ponder B.A. A clonal marker induced by mutation in mouse intestinal epithelium. Nature. 233:1988;463-466.
20. Yauk C. Monitoring for induced heritable mutations in natural populations: application of minisatellite DNA screening. Mutat. Res. 411:1998;1-10.
21. Russell W.L., Kelly E.M., Hunsicker P.R., Bangham J.W., Maddux S.C., Phipps E.L. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc. Natl. Acad. Sci., U.S.A. 76:1979;5818-5819.
22. Gossen J.A., de Leeuw W.J.F., Tan C.H.T., Zwarthoff E.C., Berends F., Lohman P.H.M., Knook D.L., Vijg J. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci., U.S.A. 86:1989;7971-7975.
23. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci., U.S.A. 88:1991;7958-7962.
24. Malling H.V., Burkhart J.G. Use of phi X174 as a shuttle vector for the study of in vivo mammalian mutagenesis. Mutat. Res. 212:1989;11-21.
25. Gorelick N.J. Overview of mutation assays in transgenic mice for routine testing. Environ. Mol. Mutagen. 25:1995;218-230.
26. Boerrigter M.E.T.I., Dollé M.E.T., Martus H.-J., Gossen J.A., Vijg J. Plasmid-based transgenic mouse model for studying in vivo mutations. Nature. 377:1995;657-659.
27. Dollé M.E.T., Martus H.-J., Novak M., van Orsouw N.J., Vijg J. Characterization of color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection. Mutagenesis. 14:1999;287-293.
28. Hoeijmakers J.H.J. Nucleotide excision repair: II. From yeast to mammals. Trends Genet. 9:1993;211-217.
29. Sancar A. Mechanisms of DNA excision repair. Science. 266:1994;1954-1956.
30. Wood R.D. DNA repair in eukaryotes. Annu. Rev. Biochem. 65:1996;135-167.
31. Sugasawa K., Ng J.M., Masutani C., Iwai S., van der Spek P.J., Eker A.P., Hanaoka F., Bootsma D., Hoeijmakers J.H.J. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell. 2:1998;223-232.
32. Hwang B.J., Ford J.M., Hanawalt P.C., Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci., U.S.A. 96:1999;424-428.
33. Hanawalt P.C, Donahue B.A., Sweder K.S. Repair and transcription. Collision or collusion? Curr. Biol. 4:1994;518-521.
34. Park C.H., Mu D., Reardon J.T., Sancar A. The general transcription-repair factor TFIIH is recruited to the excision repair complex by the XPA protein independent of the TFIIE transcription factor. J. Biol. Chem. 270:1995;4896-4902.
35. Hoeijmakers J.H.J., Egly J.-M., Vermeulen W. TFIIH: a key component in multiple DNA transactions. Curr. Opin. Genet. Dev. 6:1996;26-33.
36. Kraemer K.H. Sunlight and skin cancer: another link revealed. Proc. Natl. Acad. Sci., U.S.A. 94:1997;11-14.
37. Kraemer K.H, Lee M.M., Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis. 5:1984;511-514.
38. Nance M.A., Berry S.A. Cockayne syndrome: review of 140 cases. Am. J. Med. Genet. 42:1992;68-84.
39. de Vries A., van Oostrom C.Th.M., Hofhuis F.M., Dortant P.M., Berg R.J.W., de Gruijl F.R., Wester P.W., van Kreijl C.F., Capel P.J., van Steeg H., Verbeek S.J. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature. 377:1995;169-173.
40. de Vries A., van Oostrom C.Th.M., Dortant P.M., Beems R.B., van Kreijl C.F., Capel P.J., van Steeg H. Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice. Mol. Carcinog. 19:1997;46-53.
41. van Steeg H., Klein H., Beems R.B., van Kreijl C.F. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing. Toxicol. Pathol. 26:1998;742-749.
42. Solar and ultraviolet radiation. IARC Monogr. Eval. Carcinog. Risks Hum. 55:1992.
43. Tu Y., Dammann R., Pfeifer G.P. Sequence and time-dependent deamination of cytosine bases in UVB-induced cyclobutane pyrimidine dimers in vivo. J. Mol. Biol. 284:1998;297-311.
44. de Vries A., Berg R.J.W., Wijnhoven S., Westerman A., Wester P.W., van Kreijl C.F., Capel P.J., de Gruijl F.R., van Kranen H.J., van Steeg H. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B. Oncogene. 16:1998;2205-2212.
45. de Vries A., Gorgels T.G., Berg R.J.W., Jansen G.H., van Steeg H. Ultraviolet-B induced hyperplasia and squamous cell carcinomas in the cornea of XPA-deficient mice. Exp. Eye Res. 67:1998;53-59.
46. van Kranen H.J., de Gruijl F.R., de Vries A., Sontag Y., Wester P.W., Senden H.C., Rozemuller E., van Kreijl C.F. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice. Carcinogenesis. 16:1995;1141-1147.
47. Brown K., Burns P.A., Balmain A. Transgenic approaches to understanding the mechanisms of chemical carcinogenesis in mouse skin. Toxicol. Lett. 82/83:1995;123-130.
48. Takeuchi S., Nakatsu Y., Nakane H., Murai H., Hirota S., Kitamura Y., Okuyama A., Tanaka K. Strand specificity and absence of hot spots for p53 mutations in ultraviolet B-induced skin tumors of XPA-deficient mice. Cancer Res. 58:1998;641-646.
49. Matsumura Y., Sato M., Nishigori C., Zghal M., Yagi T., Imamura S., Takebe H. High prevalence of mutations in the p53 gene in poorly differentiated squamous cell carcinomas in xeroderma pigmentosum patients. J. Invest. Dermatol. 105:1995;399-401.
50. Brash D.E., Ziegler A., Jonason A.S., Simon J.A., Kunala S., Leffell D.J. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J. Invest. Dermatol. Symp. Proc. 1:1996;136-142.
51. Owens D.M., Wei S., Smart R.C. A multihit, multistage model of chemical carcinogenesis. Carcinogenesis. 20:1999;1837-1844.
52. Dumaz N., van Kranen H.J., de Vries A., Berg R.J.W., Wester P.W., van Kreijl C.F., Sarasin A., Daya-Grosjean L., de Gruijl F.R. The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis. 18:1997;897-904.
53. Ruven H.J., Seelen C.M., Lohman P.H., van Kranen H.J., van Zeeland A.A., Mullenders L.H.F. Strand-specific removal of cyclobutane pyrimidine dimers from the p53 gene in the epidermis of UVB-irradiated hairless mice. Oncogene. 9:1994;3427-3432.
54. Megosh L., Halpern M., Farkash E., O'Brien T.G. Analysis of ras gene mutational spectra in epidermal papillomas from K6/ODC transgenic mice. Mol. Carcinog. 22:1998;145-149.
55. de Vries A., Dollé M.E.T., Broekhof J.L.M., Muller J.J.A., Kroese E.D., van Kreijl C.F., Capel P.J.A., Vijg J., van Steeg H. Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development. Carcinogenesis. 18:1997;2327-2332.
56. Giese H., Dollé M.E.T., Hezel A., van Steeg H., Vijg J. Accelerated accumulation of somatic mutations in mice deficient in the nucleotide excision repair gene XPA. Oncogene. 18:1999;1257-1260.
57. Dollé M.E.T., Giese H., Hopkins C.L., Martus H.-J., Hausdorff J.M., Vijg J. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat. Genet. 17:1997;431-434.
58. Cole J., Arlett C.F., Norris P.G., Stephens G., Waugh A.P., Beare D.M., Green M.H. Elevated hprt mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients. Mutat. Res. 273:1992;171-178.
59. Bol S.A., van Steeg H., Jansen J.G., van Oostrom C.Th.M., de Vries A., de Groot A.J., Tates A.D., Vrieling H., van Zeeland A.A., Mullenders L.H.F. Elevated frequencies of benzo[a]pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice. Cancer Res. 58:1998;2850-2856.
60. van Oostrom C.Th.M., Boeve M., van den Berg J., de Vries A., Dollé M.E.T., Beems R.B., van Kreijl C.F., Vijg J., van Steeg H. The effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice. Environ. Mol. Mutagen. 34:1999;124-130].